Embracing Bayesian Methods in Clinical Trials: FDA's Long-Awaited Draft Guidance - PubMed
5 hours ago
- #FDA
- #Clinical Trials
- #Bayesian Methods
- The US Food and Drug Administration (FDA) has released draft guidance on Bayesian methods in clinical trials.
- This guidance highlights the FDA's commitment to modernizing clinical research.
- Bayesian methods are being embraced as a way to improve the efficiency and effectiveness of clinical trials.